Corona Immunitas, 98% of the population has Covid antibodies

The Corona Immunitas project has published the results of the first large-scale epidemiological study carried out since the Omicron variant supplanted Delta in Switzerland in early 2022. The results indicate a significant amount of antibodies present and exceptionally high neutralisation levels. The study also confirms that hybrid immunity, a combination of vaccination and infection, is the most effective. Furthermore, this study validates the vaccination plans implemented by many countries, which focus on safeguarding vulnerable individuals. The Corona Immunitas Ticino project is a joint effort between the Institute of Public Health at Università della Svizzera italiana, the Department of Business Administration, Health and Social Affairs at SUPSI, EOC, and other local partners. This initiative is a part of the wider Corona Immunitas research programme promoted by the Swiss School of Public Health (SSPH+). The project began in 2020 with the aim of evaluating the prevalence of the SARS-CoV-2 virus and the growth of immunity in the community.